Evidence map›Paper›PMID 9665961›Full record

ArticleClinical and diagnostic laboratory immunology1998

Lack of maternal antibodies to P serotypes may predispose neonates to infections with unusual rotavirus strains.

M Ramachandran, A Vij, R Kumar, B K Das, J R Gentsch, M K Bhan, R I Glass

Open access · diamondAbstract read
In one paragraph

Article in Clinical and diagnostic laboratory immunology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Rotavirus genotype distribution during the pre-vaccine period in Bolivia: 2007-2008.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2013
    Article
  3. Factors that explain excretion of enteric pathogens by persons without diarrhea.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M RamachandranDepartment of Pediatric Gastroenterology, All India Institute of Medical Sciences, New Delhi. mfr4@cdc.gov
A Vij
R Kumar
B K Das
J R Gentsch
M K Bhan
R I Glass
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rotavirus (RV) strains infecting newborns often have unique neutralization antigens (P serotypes) on their outer capsids that are distinct from those found on RV strains that cause diarrhea in older children. We examined the hypothesis that unusual RV strains preferentially infect newborns because the newborns lack maternal neutralizing antibodies to these strains. To test this hypothesis, sera and saliva samples collected from neonates infected with 116E-like (P[11]G9) strains in the maternity ward of the All India Institute of Medical Sciences (AIIMS) hospital in New Delhi were tested for neutralizing antibodies against common RV strains and those infecting newborns and these titers were compared with those of newborns who did not become infected (controls). The infected neonates had significantly lower levels of cord blood neutralizing antibodies to 116E than the controls, suggesting that immunity to neonatal RV infection is acquired transplacentally through maternal antibodies. Further, this study confirmed the immunogenicity of the AIIMS neonatal strain 116E, a vaccine candidate, in its ability to evoke a potent RV-specific immunoglobulin A and neutralizing antibody response in serum and saliva among the infected babies. Our findings have important implications for the development of an effective RV vaccine. In India, where G9 strains are common in the community, the use of 116E as a vaccine, together with the rhesus tetravalent vaccine, may provide a broader protection against all the circulating RV serotypes, including serotype G9, which is not represented in the current rhesus RV tetravalent vaccine (G1-G4).

Indexed as

Antibodies, ViralCase-Control StudiesFemaleFetal BloodHumansImmunity, Maternally-AcquiredImmunoglobulin AInfant, NewbornNeutralization TestsPolymerase Chain ReactionPregnancyRNA, ViralRotavirusRotavirus InfectionsSalivaSerotypingAntibodies, ViralImmunoglobulin ARNA, ViralViral Vaccines

Identifiers

PMID9665961
PMCPMC95612
OpenAlexW2121013329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.